Original Article

You have full text access to this OnlineOpen article

Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States

  1. Avo Artinyan MD, MS1,
  2. Brian Mailey MD1,
  3. Nicelio Sanchez-Luege BS1,
  4. Joshua Khalili BS1,
  5. Can-Lan Sun MD, PhD2,3,
  6. Smita Bhatia MD, MPH2,3,
  7. Lawrence D. Wagman MD4,
  8. Nicholas Nissen MD5,
  9. Steven D. Colquhoun MD5,
  10. Joseph Kim MD1,2,†,*

Article first published online: 25 JAN 2010

DOI: 10.1002/cncr.24817

Issue

Cancer

Cancer

Volume 116, Issue 5, pages 1367–1377, 1 March 2010

Additional Information

How to Cite

Artinyan, A., Mailey, B., Sanchez-Luege, N., Khalili, J., Sun, C.-L., Bhatia, S., Wagman, L. D., Nissen, N., Colquhoun, S. D. and Kim, J. (2010), Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer, 116: 1367–1377. doi: 10.1002/cncr.24817

Author Information

  1. 1

    Division of Oncologic Surgery, City of Hope, Duarte, California

  2. 2

    City of Hope Comprehensive Cancer Center, City of Hope, Duarte, California

  3. 3

    Department of Population Sciences, City of Hope, Duarte, California

  4. 4

    The Center for Cancer Prevention and Treatment, St. Joseph Hospital, Orange, California

  5. 5

    Division of Transplantation, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California

  1. †

    Fax: (626) 301-8865

*Assistant Professor of Surgery, City of Hope, 1500 East Duarte Road, Duarte, CA 91010

Publication History

  1. Issue published online: 18 FEB 2010
  2. Article first published online: 25 JAN 2010
  3. Manuscript Accepted: 5 JUN 2009
  4. Manuscript Revised: 4 JUN 2009
  5. Manuscript Received: 10 MAR 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (308K)

REFERENCES

  • 1
    El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004; 127( 5 suppl 1): S27-S34.
  • 2
    Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepat. 2007; 14: 107-115.
    Direct Link:
  • 3
    Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health. 2000; 90: 1562-1569.
  • 4
    El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol. 2000; 95: 3566-3573.
    Direct Link:
  • 5
    Liu JH, Chen PW, Asch SM, Busuttil RW, Ko CY. Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol. 2004; 11: 298-303.
  • 6
    El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology. 2001; 33: 62-65.
    Direct Link:
  • 7
    Davila JA, El-Serag HB. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol. 2006; 4: 104-110.
  • 8
    Sloane D, Chen H, Howell C. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. J Natl Med Assoc. 2006; 98: 1934-1939.
  • 9
    Di Bisceglie AM, Lyra AC, Schwartz M, et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol. 2003; 98: 2060-2063.
  • 10
    Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334-357.
  • 11
    El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003; 139: 817-823.
  • 12
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER Limited-Use Data (1973-2004). Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. April, 2008. Available at: http://www.seer.cancer.gov. Accessed November 2008.
  • 13
    FritzA, PercyC, JackA, et al, eds. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
  • 14
    United Network for Organ Sharing. UNOS data. Available at: http://www.unos.org/data/about/collection.asp, data received from UNOS February, 2008. Accessed November 2008.
  • 15
    Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334: 693-699.
  • 16
    Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000; 31: 864-871.
    Direct Link:
  • 17
    Poon RT. Current techniques of liver transection. HPB (Oxford). 2007; 9: 166-173.
  • 18
    Ishizaki Y, Kawasaki S. The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol. 2008; 43: 18-26.
  • 19
    Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol. 2003; 21: 4329-4335.
  • 20
    Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg. 2002; 236: 397-406.
  • 21
    Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004; 240: 698-708.
  • 22
    McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr. International trends and patterns of primary liver cancer. Int J Cancer. 2001; 94: 290-296.
    Direct Link:
  • 23
    Eckhoff DE, McGuire BM, Young CJ, et al. Race: a critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation? Liver Transpl Surg. 1998; 4: 499-505.
    Direct Link:
  • 24
    Reid AE, Resnick M, Chang Y, Buerstatte N, Weissman JS. Disparity in use of orthotopic liver transplantation among blacks and whites. Liver Transpl. 2004; 10: 834-841.
    Direct Link:
  • 25
    Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008; 300: 2371-2378.
  • 26
    Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet. 2002; 359: 287-293.
  • 27
    Yoo HY, Thuluvath PJ. Outcome of liver transplantation in adult recipients: influence of neighborhood income, education, and insurance. Liver Transpl. 2004; 10: 235-243.
    Direct Link:
  • 28
    Aguilera V, Berenguer M, Rubin A, et al. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): post-transplantation outcome—comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis. Liver Transpl. 2009; 15: 79-87.
    Direct Link:
  • 29
    Smallwood GA, Coffey G, Davis L, Martinez E, Stieber AC, Heffron TG. Hepatitis C treatment outcomes of African Americans following liver transplantation. Transplant Proc. 2002; 34: 3317-3318.
  • 30
    Mehra MR, Uber PA, Scott RL, Park MH. Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. Transplantation. 2002; 74: 1568-1573.
View Full Article (HTML) Get PDF (308K)